Effects of estrogen replacement therapy on estrogen receptor expression and immunoregulatory cytokine secretion in surgically induced menopausal women

Journal of Reproductive Immunology

Volumn 81, Issue 1, 2009, Pages 89-96

  Xia, Xian ^a   Zhang, Shaofen ^a   Yu, Yinhua ^a   Zhao, Naiqing ^a   Liu, Ruizi ^a   Liu, Kangda ^a   Chen, Xun ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Estrogen receptors; Estrogen replacement therapy; Immunoregulatory cytokines; Surgically induced menopausal women; T lymphocytes

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FOLLITROPIN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DOSAGE FORM COMPARISON; ESTROGEN THERAPY; FEMALE; HUMAN; HYSTERECTOMY; IMMUNOREGULATION; MENOPAUSAL SYNDROME; MENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY; T LYMPHOCYTE; TH1 CELL; TH2 CELL; TREATMENT OUTCOME;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, ORAL; CELLS, CULTURED; CYTOKINES; ENDOMETRIOSIS; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION; HORMONE REPLACEMENT THERAPY; HUMANS; HYSTERECTOMY; LEIOMYOMA; MENOPAUSE, PREMATURE; MIDDLE AGED; OVARIECTOMY; T-LYMPHOCYTES; UTERINE NEOPLASMS;

EID: 67649816812     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2009.02.008     Document Type: Article

References (40)

1. Abbas A.K., Murphy K.M., and Sher A. Functional diversity of helper T lymphocytes. Nature 383 (1996) 787-793
2. Berg G., Ekerfelt C., Hammar M., Lindgren R., Matthiesen L., and Ernerudh J. Cytokine changes in postmenopausal women treated with estrogens: a placebo-controlled study. Am. J. Reprod. Immunol. 48 (2002) 63-69
3. Bukowska H., Stanosz S., Zochowska E., Millo B., Sieja K., Chelstowski K., and Naruszewicz M. Does the type of hormone replacement therapy affect lipoprotein (a), homocysteine, and C-reactive protein levels in postmenopausal women?. Metabolism 54 (2005) 72-78
4. Cioffi M., Esposito K., Vietri M.T., Gazzerro P., D'Auria A., Ardovino I., Puca G.A., and Molinari A.M. Cytokine pattern in postmenopause. Maturitas 41 (2002) 187-192
5. Deguchi K., Kamada M., Irahara M., Maegawa M., Yamamoto S., Ohmoto Y., Murata K., Yasui T., Yamano S., and Aono T. Postmenopausal changes in production of type 1 and type 2 cytokines and the effects of hormone replacement therapy. Menopause 8 (2001) 266-272
6. Ehrchen J., Sindrilaru A., Grabbe S., Schönlau F., Schlesiger C., Sorg C., Scharffetter-Kochanek K., and Sunderkötter C. Senescent BALB/c mice are able to develop resistance to Leishmania major infection. Infect. Immun. 72 (2004) 5106-5114
7. Erlandsson M.C., Ohlsson C., Gustafsson J.A., and Carlsten H. Role of oestrogen receptors alpha and beta in immune organ development and in oestrogen-mediated effects on thymus. Immunology 103 (2001) 17-25
8. Fahlman M.M., Boardley D., Flynn M.G., Bouillon L.E., Lambert C.P., and Braun W.A. Effects of hormone replacement therapy on selected indices of immune function in postmenopausal women. Gynecol. Obstet. Invest. 50 (2000) 189-193
9. Greendale G.A., Lee N.P., and Arriola E.R. The menopause. Lancet 353 (1999) 571-580
10. Grubeck-Loebenstein B., and Wick G. The aging of the immune system. Adv. Immunol. 80 (2002) 243-284
11. Hough H.J., Failla M.L., and Ludwig D.A. Active lifestyle offsets HRT-induced suppression of T cell reactivity to mitogens. Maturitas 33 (1999) 211-218
12. Jewelewicz R. New developments in topical estrogen therapy. Fertil. Steril. 67 (1997) 1-12
13. Kamada M., Irahara M., Maegawa M., Ohmoto Y., Murata K., Yasui T., Yamano S., and Aono T. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol. Obstet. Invest. 52 (2001) 82-88
14. Kamada M., Irahara M., Maegawa M., Ohmoto Y., Takeji T., Yasui T., and Aono T. Postmenopausal changes in serum cytokine levels and hormone replacement therapy. Am. J. Obstet. Gynecol. 184 (2001) 309-314
15. Kamada M., Irahara M., Maegawa M., Yasui T., Takeji T., Yamada M., Tezuka M., Kasai Y., and Aono T. Effect of hormone replacement therapy on postmenopausal changes of lymphocytes and T cell subsets. J. Endocrinol. Invest. 23 (2000) 376-382
16. Kumru S., Godekmerdan A., and Yilmaz B. Immune effects of surgical menopause and estrogen replacement therapy in peri-menopausal women. J. Reprod. Immunol. 63 (2004) 31-38
17. Kupperman H.S., Wetchler B.B., and Blatt M.H. Contemporary therapy of the menopausal syndrome. JAMA 21 (1959) 1627-1637
18. Lambert K.C., Curran E.M., Judy B.M., Milligan G.N., Lubahn D.B., and Estes D.M. Estrogen receptor alpha (ERalpha) deficiency in macrophages results in increased stimulation of CD4+ T cells while 17beta-estradiol acts through ERalpha to increase IL-4 and GATA-3 expression in CD4+ T cells independent of antigen presentation. J. Immunol. 175 (2005) 5716-5723
19. Lang T.J. Estrogen as an immunomodulator. Clin. Immunol. 113 (2004) 224-230
20. Marin-Castano M.E., Elliot S.J., Potier M., Karl M., Striker L.J., Striker G.E., Csaky K.G., and Cousins S.W. Regulation of estrogen receptors and MMP-2 expression by estrogens in human retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 44 (2003) 50-59
21. Nancy P., and Berrih-Aknin S. Differential estrogen receptor expression in autoimmune myasthenia gravis. Endocrinology 146 (2005) 2345-2353
22. Nilsson S., Makela S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., and Gustafsson J.-A. Mechanisms of estrogen action. Physiol. Rev. 81 (2001) 1535-1565
23. Peeyananjarassri K., and Baber R. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials. Climacteric 8 (2005) 13-23
24. Phiel K.L., Henderson R.A., Adelman S.J., and Elloso M.M. Differential estrogen receptor gene expression in human peripheral blood mononuclear cell populations. Immunol. Lett. 97 (2005) 107-113
25. Porter V.R., Greendale G.A., Schocken M., Zhu X., and Effros R.B. Immune effects of hormone replacement therapy in post-menopausal women. Exp. Gerontol. 36 (2001) 311-326
26. Potts R.O., and Lobo R.A. Transdermal drug delivery: clinical considerations for the obstetrician-gynecologist. Obstet. Gynecol. 105 (2005) 953-961
27. Reiner S.L., and Seder R.A. T helper cell differentiation in immune response. Curr. Opin. Immunol. 8 (1995) 360-366
28. Rider V., Li X., Peterson G., Dawson J., Kimler B.F., and Abdou N.I. Differential expression of estrogen receptors in women with systemic lupus erythematosus. J. Rheumatol. 33 (2006) 1093-1101
29. Rosen C.J., and Kessenich C.R. The pathophysiology and treatment of post-menopausal osteoporosis. An evidence-based approach to estrogen replacement therapy. Endocrinol. Metab. Clin. North Am. 26 (1997) 295-311
30. Sakata-Kaneko S., Wakatsuki Y., Matsunaga Y., Usui T., and Kita T. Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin. Exp. Immunol. 120 (2000) 267-273
31. Salem M.L. Estrogen, a double-edged sword: modulation of Th1- and Th2-mediated inflammations by differential regulation of Th1/Th2 cytokine production. Curr. Drug Targets Inflamm. Allergy (2004) 97-104
32. Samy T.S., Schwacha M.G., Cioffi W.G., Bland K.I., and Chaudry I.H. Androgen and estrogen receptors in splenic T lymphocytes: effects of flutamide and trauma-hemorrhage. Shock 14 (2000) 465-470
33. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., Parson W., Bock G., Schonitzer D., Trannov E., and Grubeck-Loebenstein B. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168 (2002) 5893-5899
34. Stopinska-Gluszak U., Waligora J., Grzela T., Gluszak M., Jozwiak J., Radomski D., Roszkowski P.I., and Malejczyk J. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women. J. Reprod. Immunol. 69 (2006) 65-75
35. Suenaga R., Rider V., Evans M.J., and Abdou N.I. In vitro-activated human lupus T cells express normal estrogen receptor proteins which bind to the estrogen response element. Lupus 10 (2001) 116-122
36. Takao T., Kumagai C., Hisakawa N., Matsumoto R., and Hashimoto K. Effect of 17beta-estradiol on tumor necrosis factor-alpha-induced cytotoxicity in the human peripheral T lymphocytes. J. Endocrinol. 184 (2005) 191-197
37. The Executive Committee of IMS. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Climacteric 7 (2004) 8-11
38. The Executive Committee of IMS. Guidelines for the hormone treatment of women in the menopausal transition and beyond. Maturitas 51 (2005) 15-20
39. Van Gestel I., IJland M.M., Hoogland H.J., and Evers J.L. Endometrial wave-like activity in the non-pregnant uterus. Hum. Reprod. Update 9 (2003) 131-138
40. Yang J.H., Chen C.D., Wu M.Y., Chao K.H., Yang Y.S., and Ho H.N. Hormone replacement therapy reverses the decrease in natural killer cytotoxicity but does not reverse the decreases in the T-cell subpopulation or interferon-gamma production in postmenopausal women. Fertil. Steril. 74 (2000) 261-267